Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Change in Cash (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Change in Cash for 5 consecutive years, with -$8.7 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 26.8% to -$8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$54.3 million through Dec 2025, down 25.14% year-over-year, with the annual reading at -$54.3 million for FY2025, 25.14% down from the prior year.
  • Change in Cash for Q4 2025 was -$8.7 million at Werewolf Therapeutics, up from -$11.9 million in the prior quarter.
  • The five-year high for Change in Cash was $99.6 million in Q2 2021, with the low at -$23.9 million in Q2 2024.
  • Average Change in Cash over 5 years is -$1.7 million, with a median of -$10.8 million recorded in 2022.
  • Peak annual rise in Change in Cash hit 378.99% in 2023, while the deepest fall reached 620.29% in 2023.
  • Over 5 years, Change in Cash stood at -$12.9 million in 2021, then increased by 13.75% to -$11.1 million in 2022, then skyrocketed by 138.54% to $4.3 million in 2023, then tumbled by 375.71% to -$11.8 million in 2024, then increased by 26.8% to -$8.7 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$8.7 million, -$11.9 million, and -$14.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.